308 related articles for article (PubMed ID: 18429789)
1. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
Tolland JP; Devereux C; Jones FC; Bingham EA
Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
[TBL] [Abstract][Full Text] [Related]
2. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide].
Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M
Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665
[No Abstract] [Full Text] [Related]
3. Sclerodermatous chronic graft-versus-host disease presenting with dysphagia.
Tamagawa R; Takenaka H; Katoh N; Shimazaki C; Bamba H; Kishimoto S
Eur J Dermatol; 2006; 16(1):92-3. PubMed ID: 16436353
[No Abstract] [Full Text] [Related]
4. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
[TBL] [Abstract][Full Text] [Related]
5. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
[TBL] [Abstract][Full Text] [Related]
7. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
Kim JB; Liakopoulou E; Watson JS
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
[TBL] [Abstract][Full Text] [Related]
9. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
White JM; Creamer D; du Vivier AW; Pagliuca A; Ho AY; Devereux S; Salisbury JR; Mufti GJ
Br J Dermatol; 2007 May; 156(5):1032-8. PubMed ID: 17419693
[TBL] [Abstract][Full Text] [Related]
10. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
[No Abstract] [Full Text] [Related]
11. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic graft-versus-host disease: a report of two cases and literature review.
Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus.
Goiriz R; Peñas PF; Delgado-Jiménez Y; Fernández-Herrera J; Aragüés-Montañés M; Fraga J; García-Díez A
Lupus; 2008 Jun; 17(6):591-5. PubMed ID: 18539715
[TBL] [Abstract][Full Text] [Related]
14. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
15. Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha.
White JM; Devereux S; Pagliuca A; Salisbury JR; du Vivier AW; Creamer D
Br J Dermatol; 2006 Sep; 155(3):621-3. PubMed ID: 16911292
[TBL] [Abstract][Full Text] [Related]
16. Update on ocular graft versus host disease.
Kim SK
Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
[TBL] [Abstract][Full Text] [Related]
17. Many faces of graft-versus-host disease.
Peñas PF; Zaman S
Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830
[TBL] [Abstract][Full Text] [Related]
18. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
[TBL] [Abstract][Full Text] [Related]
19. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Epstein JB; Nantel S; Sheoltch SM
Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
[TBL] [Abstract][Full Text] [Related]
20. [Pyogenic granuloma of the tongue in chronic graft versus host disease].
Bachmeyer C; Devergie A; Mansouri S; Dubertret L; Aractingi S
Ann Dermatol Venereol; 1996; 123(9):552-4. PubMed ID: 9615106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]